| Biologics in rheumatoid arthritis - recommendations for Swiss practice. | |
| | |
MedLine Citation:
|
PMID: 21557111 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The new paradigm of therapy in rheumatoid arthritis is to aim toward early and complete remission, using a larger use of conventional DMARDs and biologic agents. The present recommendations were established through a consensus to help practitioners in their daily use of those agents, to reflect the current "best practice" in Switzerland. |
| | |
Authors:
|
J Dudler; B Möller; B A Michel; P Villiger |
Publication Detail:
|
Type: Journal Article Date: 2011-05-10 |
Journal Detail:
|
Title: Swiss medical weekly Volume: 141 ISSN: 1424-3997 ISO Abbreviation: Swiss Med Wkly Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-05-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100970884 Medline TA: Swiss Med Wkly Country: Switzerland |
Other Details:
|
Languages: eng Pagination: w13189 Citation Subset: IM |
Affiliation:
|
Department of Rheumatology, University Hospital Bern, 3010 Bern, CH. jean.dudler@chuv.ch. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The value of personal health records for chronic disease management: what do we know?
Next Document: Chronic liver inflammation and hepatocellular carcinoma: persistence matters.